Molecular dynamics simulation in virus research

Frontiers in Microbiology

Volumn 3, Issue JUL, 2012, Pages

  Ode, Hirotaka ^a,b   Nakashima, Masaaki ^a,c   Kitamura, Shingo ^a,c   Sugiura, Wataru ^a,d   Sato, Hironori ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coarse grained MD; MD simulation; Protein dynamics; Three dimensional structure; Viral protein

Indexed keywords

EID: 84875764965     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00258     Document Type: Review

References (124)

1. Abbondanzieri, E. A., Bokinsky, G., Rausch, J. W., Zhang, J. X., Le Grice, S. F., and Zhuang, X. (2008). Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453, 184-189.
2. Adcock, S. A., and McCammon, J. A. (2006). Molecular dynamics: survey of methods for simulating the activity of proteins. Chem. Rev. 106, 1589-1615.
3. Amaro, R. E., Swift, R. V., Votapka, L., Li, W. W., Walker, R. C., and Bush, R. M. (2011). Mechanism of 150-cavity formation in influenza neuraminidase. Nat. Commun. 2, 388.
4. Arkhipov, A., Freddolino, P. L., and Schulten, K. (2006). Stability and dynamics of virus capsids described by coarse-grained modeling. Structure 14, 1767-1777.
5. Arkhipov, A., Roos, W. H., Wuite, G. J., and Schulten, K. (2009). Elucidating the mechanism behind irreversible deformation of viral capsids. Biophys. J. 97, 2061-2069.
6. Astumian, R. D.(1997).Thermodynamics and kinetics of a brownian motor. Science 276, 917-922.
7. Autore, F., Bergeron, J. R., Malim, M. H., Fraternali, F., and Huthoff, H. (2010). Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studiesby molecular dynamics simulations. PLoS ONE 5:e11515. doi: 10.1371/journal.pone.0011515
8. Ayton, G. S., and Voth, G. A. (2010). Multiscale computer simulation of the immature HIV-1 virion. Biophys. J. 99, 2757-2765.
9. Baker, D., and Sali, A. (2001). Protein structure prediction and structural genomics. Science 294, 93-96.
10. Batista, P. R., Wilter, A., Durham, E. H., and Pascutti, P. G. (2006). Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia. Cell Biochem. Biophys. 44, 395-404.
11. Borhani, D. W., and Shaw, D. E. (2012). The future of molecular dynamics simulations in drug discovery. J. Comput. Aided. Mol. Des. 26, 15-26.
12. Brooks, B. R., Brooks, C. L. 3rd., Mackerell, A. D. Jr., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., Kuczera, K., Lazaridis, T., Ma, J., Ovchinnikov, V., Paci, E., Pastor, R. W., Post, C. B., Pu, J. Z., Schaefer, M., Tidor, B., Venable, R. M., Woodcock, H. L., Wu, X., Yang, W., York, D. M., andKarplus,M. (2009). CHARMM: the biomolecular simulation program. J. Comput. Chem. 30, 1545-1614.
13. Cameron, C. E., Moustafa, I. M., and Arnold, J. J. (2009). Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase? Curr. Opin. Struct. Biol. 19, 768-774.
14. Carvalho, A. T., Fernandes, P. A., and Ramos, M. J. (2006). Insights on resistance to reverse transcriptase: the different patterns of interaction of the nucleoside reverse transcriptase inhibitors in the deoxyribonucleotide triphosphate binding site relative to the normal substrate. J. Med. Chem. 49, 7675-7682.
15. Carvalho, A. T., Fernandes, P. A., and Ramos, M. J. (2007). The excision mechanism in reverse transcriptase: pyrophosphate leaving and fingers opening are uncoupled events with the analogues AZT and d4T. J. Phys. Chem. B111, 12032-12039.
16. Case, D. A., Cheatham, T. E., 3rd, Darden, T., Gohlke, H., Luo, R., Merz, K. M. Jr., Onufriev, A., Simmerling, C., Wang, B., and Woods, R. J. (2005). The amber biomolecular simulation programs. J. Comput. Chem. 26, 1668-1688.
17. Chang, C. E., Shen, T., Trylska, J., Tozzini, V., and McCammon, J. A. (2006). Gated binding of ligands to HIV-1 protease: brownian dynamics simulations in a coarse-grained model. Biophys. J. 90, 3880-3885.
18. Chen, J., Zhang, S., Liu, X., and Zhang, Q. (2010). Insights into drug resistance of mutations D30N and I50V to HIV-1 protease inhibitor TMC-114, free energy calculation and molecular dynamic simulation. J. Mol. Model. 16, 459-468.
19. Cortez, K. J., and Maldarelli, F. (2011). Clinical management of HIV drug resistance. Viruses 3, 347-378.
20. Da, L. T., and Wu, Y. D. (2011). Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5. J. Chem. Inf. Model. 51, 359-369.
21. Datta, S. A., Temeselew, L. G., Crist, R. M., Soheilian, F., Kamata, A., Mirro, J., Harvin, D., Nagashima, K., Cachau, R. E., and Rein, A. (2011). On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? J. Virol. 85, 4111-4121.
22. Day, J., Kuznetsov, Y. G., Larson, S. B., Greenwood, A., and McPherson, A. (2001). Biophysical studies on the RNA cores of satellite tobacco mosaic virus. Biophys. J. 80, 2364-2371.
23. Deng, N. J., Zheng, W., Gallicchio, E., and Levy, R. M. (2011). Insights into the dynamics of HIV-1 protease: a kinetic networkmodel constructed from atomistic simulations. J. Am. Chem. Soc. 133, 9387-9394.
24. Dirauf, P., Meiselbach, H., and Sticht, H. (2010). Effects of the V82A and I54V mutations on the dynamics and ligand binding properties of HIV-1 protease. J. Mol. Model. 16, 1577-1583.
25. Dodson, G. G., Lane, D. P., and Verma,C.S. (2008). Molecular simulations of protein dynamics: new windows on mechanisms in biology. EMBORep. 9, 144-150.
26. Douglas, J. L., Gustin, J. K., Viswanathan, K., Mansouri, M., Moses, A. V., and Fruh, K. (2010). The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6:e1000913. doi: 10.1371/journal.ppat.1000913
27. Dror, R. O., Jensen, M. O., Borhani, D W., and Shaw, D. E. (2010). Exploring atomic resolution physiology on a femtosec ond to millisecond timescale using molecular dynamics sim ulations. J. Gen. Physiol. 135, 555-562.
28. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., and Obradovic, Z. (2002). Intrinsic disorder and protein function. Biochemistry 41, 6573-6582.
29. Dunker, A. K., Cortese, M. S., Romero, P., Iakoucheva, L. M., and Uversky, V. N. (2005). Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J. 272, 5129-5148.
30. Dunker, A. K., Silman, I., Uversky, V. N., and Sussman, J. L. (2008). Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 18, 756-764.
31. Dunn, B. M., Goodenow, M. M., Gustchina, A., and Wlodawer, A. (2002). Retroviral proteases. Genome Biol. 3, Reviews3006.
32. Durrant, J. D., and McCammon, J. A. (2011). Molecular dynamics simulations and drug discovery. BMCBiol. 9,71.
33. Dyson, H. J., and Wright, P. E. (2005). Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell. Biol. 6, 197-208.
34. Eisenmesser, E. Z., Millet, O., Labeikovsky, W., Korzhnev, D. M., Wolf-Watz, M., Bosco, D. A., Skalicky, J. J., Kay, L. E., and Kern, D. (2005). Intrinsic dynamics of an enzyme underlies catalysis. Nature 438, 117-121.
35. Flechsig, H., and Mikhailov, A. S. (2010). Tracing entire operation cycles of molecular motor hepatitis C virus helicase in structurally resolved dynamical simulations.Proc. Natl. Acad Sci. U.S.A. 107, 20875-20880.
36. Foulkes-Murzycki, J. E., Scott, W. R., and Schiffer, C. A. (2007). Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease. Structure 15, 225-233.
37. Grzela, R., Szolajska, E., Ebel, C., Madern, D., Favier, A., Wojtal, I., Zagorski, W., and Chroboczek, J. (2008). Virulence factor of potato virus Y, genome-attached terminal protein VPg, is a highly disordered protein. J. Biol. Chem. 283, 213-221.
38. Gu, M., and Rice, C. M. (2010). Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism. Proc. Natl. Acad. Sci. U.S.A. 107, 521-528.
39. Gu, R. X., Liu, L. A., Wei, D. Q., Du, J. G., Liu, L., and Liu, H. (2011). Free energy calculations on the two drug binding sites in the M2 proton channel. J. Am. Chem. Soc. 133, 10817-10825.
40. Habchi, J., and Longhi, S. (2012).Structural disorder within paramyxovirus nucleoproteinsand phosphoproteins. Mol. Biosyst. 8,69-81.
41. Haynes, C., Oldfield, C. J., Ji, F., Klitgord, N., Cusick, M. E., Radivojac, P., Uversky, V. N., Vidal, M., and Iakoucheva, L. M. (2006). Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput. Biol. 2:e100. doi: 10.1371/journal.pcbi.0020100
42. Henzler-Wildman, K., and Kern, D. (2007). Dynamic personalities of proteins. Nature 450, 964-972.
43. Henzler-Wildman, K. A., Lei, M., Thai, V., Kerns, S. J., Karplus, M., and Kern, D. (2007). A hierarchy of timescales in protein dynamics is linked to enzyme catalysis. Nature 450,913-916.
44. Hornak, V., Okur, A., Rizzo, R. C., and Simmerling, C. (2006). HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations. Proc. Natl. Acad. Sci. U.S.A. 103,915-920.
45. Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradovic, Z., and Dunker, A. K. (2002). Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323, 573-584.
46. Ishima, R., and Torchia, D. A. (2000). Protein dynamics from NMR. Nat. Struct. Biol. 7, 740-743.
47. Jiang, J., and Laliberte, J. F. (2011). The genome-linked protein VPgof plant viruses-a protein with many partners. Curr. Opin. Virol. 1, 347-354.
48. Joyce, C. M., and Steitz, T. A. (1994). Function and structure relationships in DNA polymerases. Annu. Rev. Biochem. 63, 777-822.
49. Kagan, R. M., Shenderovich, M. D., Heseltine, P. N., and Ramnarayan, K. (2005). Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir. Protein Sci. 14, 1870-1878.
50. Kar, P., and Knecht, V (2012). Origin of decrease in potency of darunavir and two related antiviral inhibitors against HIV-2 compared to HIV-1 protease. J. Phys. Chem. B 116, 2605-2614.
51. Karplus, M., and Kuriyan, J. (2005). Molecular dynamics and protein function. Proc. Natl. Acad. Sci. U.S.A. 102, 6679-6685.
52. Karplus, M., and McCammon, J. A. (2002). Molecular dynamics simulations of biomolecules. Nat. Struct. Biol. 9, 646-652.
53. Karplus, M., and Petsko, G. A. (1990). Molecular dynamics simulations in biology. Nature 347, 631-639.
54. Karthik, S., and Senapati, S. (2011). Dynamic flaps in HIV-1 protease adopt unique ordering at different stages in the catalytic cycle. Proteins 79, 1830-1840.
55. Kasson, P. M. (2012). Receptor binding by influenza virus: using computational techniques to extend structural data. Biochemistry 51, 2359-2365.
56. Kirmizialtin, S., Nguyen, V., Johnson, K. A., and Elber, R. (2012). How conformational dynamics of DNA polymerase select correct substrates: experiments and simulations. Structure 20, 618-627.
57. Kobayashi, T., Ode, H., Yoshida, T., Sato, K., Gee, P., Yamamoto, S. P., Ebina, H., Strebel, K., Sato, H., and Koyanagi, Y. (2011). Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J. Virol. 85, 932-945.
58. Krishna, V., Ayton, G. S., and Voth, G. A. (2010). Role of protein interactions in defining HIV-1 viral capsid shape and stability: a coarsegrained analysis. Biophys. J. 98, 18-26.
59. Lamers, M. H., Georgescu, R. E., Lee, S. G., ODonnell, M., and Kuriyan, J. (2006). Crystal structure of the catalytic alpha subunit of E. coli replicative DNA polymerase III. Cell 126,881-892.
60. Larsson, D. S., Liljas, L., and van der Spoel, D. (2012). Virus capsid dissolution studied by microsecond molecular dynamics simulations. PLoS Comput. Biol. 8:e1002502. doi: 10.1371/journal.pcbi.1002502
61. Le, L., Lee, E. H., Hardy, D. J., Truong, T. N., and Schulten, K. (2010). Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases. PLoS Comput. Biol. 6:e1000939. doi: 10.1371/journal.pcbi.1000939
62. Lee, D. J., and Robinson, W E. Jr. (2006). Preliminary mapping of a putative inhibitor-binding pocket for human immunodeficiency virus type 1 integrase inhibitors. Antimicrob. Agents Chemother. 50, 134-142.
63. Leonov, H., Astrahan, P., Krugliak, M., and Arkin, I. T. (2011). How do aminoadamantanes block the influenza M2 channel, and how does resistance develop? J. Am. Chem. Soc. 133,9903-9911.
64. Lindorff-Larsen, K., Maragakis, P., Piana, S., Eastwood, M. P., Dror, R. O., and Shaw, D. E. (2012). Systematic validation of protein force fields against experimental data. PLoS ONE 7:e32131. doi: 10.1371/journal.pone.0032131
65. Lu, H. P., Xun, L., and Xie, X. S. (1998). Single-molecule enzymatic dynamics. Science 282, 1877-1882.
66. Maeda, K., Das, D., Yin, P. D., Tsuchiya, K., Ogata-Aoki, H., Nakata, H., Norman, R. B., Hackney, L. A., Takaoka, Y., and Mitsuya, H. (2008). Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.J. Mol. Biol. 381, 956-974.
67. Malim, M. H., and Bieniasz, P. D. (2012). HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2, a006940.
68. Marti-Renom, M. A., Stuart, A. C., Fiser, A., Sanchez, R., Melo, F., and Sali, A. (2000). Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29, 291-325.
69. Matsuyama, S., Aydan, A., Ode, H., Hata, M., Sugiura, W., and Hoshino, T. (2010). Structural and energetic analysis on the complexes of clinically isolated subtype C HIV-1 proteases and approved inhibitors by molecular dynamics simulation. J. Phys. Chem. B 114, 521-530.
70. McCammon, J. A., Gelin, B. R., and Karplus, M. (1977). Dynamics of folded proteins. Nature 267, 585-590.
71. Merchant, B. A., and Madura, J. D. (2011). A review of coarse-grained molecular dynamics techniques to access extended spatial and temporal scales in biomolecular simulations. Annu. Rep. Comput. Chem. 7, 67-87.
72. Miyamoto, T., Yokoyama, M., Kono, K., Shioda, T., Sato, H., and Nakayama, E. E. (2011). A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5alpha. PLoS ONE 6:e22779. doi: 10.1371/journal.pone.0022779
73. Moustafa, I. M., Shen, H., Morton, B., Colina, C. M., and Cameron, C. E. (2011). Molecular dynamics simulations of viral RNA polymer ases link conserved and correlated motions of functional elements to fidelity. J.Mol.Biol. 410, 159-181.
74. Myong, S., Bruno, M. M., Pyle, A. M., and Ha, T. (2007). Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase. Science 317, 513-516.
75. Naganawa, S., Yokoyama, M., Shiino, T., Suzuki, T., Ishigatsubo, Y., Ueda, A., Shirai, A., Takeno, M., Hayakawa, S., Sato, S., Tochikubo, O., Kiyoura, S., Sawada, K., Ikegami, T., Kanda, T., Kitamura, K., and Sato, H. (2008). Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity. PLoS ONE 3:e3206. doi: 10.1371/journal.pone.0003206
76. Neil, S., and Bieniasz, P. (2009). Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 29,569-580.
77. Nicholson, L. K., Yamazaki, T., Torchia, D. A., Grzesiek, S., Bax, A., Stahl, S. J., Kaufman, J. D., Wingfield, P. T., Lam, P. Y. S., Jadhav, P. K., Hodge, C. N., Domaille, P. J., and Chang, C.-H. (1995). Flexibility and function in HIV-1 protease. Nat. Struct. Biol. 2, 274-280.
78. Ode, H., Matsuyama, S., Hata, M., Hoshino, T., Kakizawa, J., and Sugiura, W. (2007a). Mechanism of drug resistance due to N88S in CRF01_AE HIV-1 protease, analyzed by molecular dynamics simulations. J. Med. Chem. 50, 1768-1777.
79. Ode, H., Matsuyama, S., Hata, M., Neya, S., Kakizawa, J., Sugiura, W., and Hoshino, T. (2007b). Computational characterization of structural role of the non-active site mutation M36I of human immunodeficiency virus type 1 protease. J. Mol Biol. 370, 598-607.
80. Ode, H., Neya, S., Hata, M., Sugiura, W., and Hoshino, T. (2006).Computational simulations of HIV-1 proteases - multi-drug resistance due to nonactive site mutation L90M. J. Am. Chem. Soc. 128, 7887-7895.
81. Ode, H., Ota, M., Neya, S., Hata, M., Sugiura, W., and Hoshino, T. (2005). Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases. J. Phys. Chem. B 109, 565-574.
82. Ode, H., Yokoyama, M., Kanda, T., and Sato, H. (2011). Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability. J. Mol. Model. 17,391-399.
83. Okimoto, N., Futatsugi, N., Fuji, H., Suenaga, A., Morimoto, G., Yanai, R., Ohno, Y., Narumi, T., and Taiji, M. (2009). High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations. PLoS Comput. Biol. 5:e1000528. doi: 10.1371/journal.pcbi.1000528
84. Onyango, C. O., Leligdowicz, A., Yokoyama, M., Sato, H., Song, H., Nakayama, E. E., Shioda, T., de Silva, T., Townend, J., Jaye, A., Whittle, H., Rowland-Jones, S., and Cotten, M. (2010). HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine 28(Suppl. 2), B60-B67.
85. Ozen, A., Haliloglu, T., and Schiffer, C. A. (2011). Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope. J. Mol. Biol. 410, 726-744.
86. Pearlman, D. A., Case, D. A., Caldwell, J. W., Ross, W. S., Cheatham, T. E. I., DeBolt, S., Ferguson, D., Seibel, G., and Kollman, P. (1995). AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comp. Phys. Commun. 91, 1-41.
87. Perryman, A. L., Lin, J. H., and McCammon, J. A. (2004). HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs. Protein Sci. 13, 1108-1123.
88. Pettit, S. C., Henderson, G. J., Schiffer, C. A., and Swanstrom, R. (2002). Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease. J. Virol. 76, 10226-10233.
89. Pettit, S. C., Moody, M. D., Wehbie, R. S., Kaplan, A. H., Nantermet, P. V., Klein, C. A., and Swanstrom, R. (1994). The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68, 8017-8027.
90. Piana, S., Carloni, P., and Rothlisberger, U. (2002). Drug resistance in HIV-1 protease: flexibility-assisted mechanism of compensatory mutations. Protein Sci. 11,2393-2402.
91. Rantalainen, K. I., Eskelin, K., Tompa, P., and Makinen, K. (2011). Structural flexibility allows the functional diversity of potyvirus genome-linked protein VPg. J. Virol. 85, 2449-2457.
92. Rantalainen, K. I., Uversky, V. N., Permi, P., Kalkkinen, N., Dunker,A.K., and Makinen, K. (2008).Potato virus A genome-linked protein VPg is an intrinsically disordered molten globule-like proteinwith a hydrophobic core. Virology 377, 280-288.
93. Reboul, C. F., Meyer, G. R., Porebski,B.T., Borg, N. A., and Buckle,A. M. (2012). Epitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complex. PLoS Comput. Biol. 8:e1002404. doi:10.1371/journal.pcbi.1002404
94. Reingewertz, T. H., Shalev, D. E., and Friedler, A. (2010). Structural disorder in the HIV-1Vif protein and interaction-dependent gain of structure. Protein Pept. Lett. 17, 988-998.
95. Rodriguez-Barrios, F., Balzarini, J., and Gago, F. (2005). The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations. J. Am. Chem. Soc. 127, 7570-7578.
96. Rodriguez-Barrios, F., and Gago, E (2004). Understanding the basis of resistance in the irksome Lys103Asn HIV-1 reverse transcriptase mutant through targeted molecular dynamics simulations. J. Am. Chem. Soc. 126,15386-15387.
97. Sadiq, S. K., Wan, S., and Coveney, P. V. (2007). Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site. Biochemistry 46, 14865-14877.
98. Sadiq, S. K., Wright, D. W., Kenway, O. A., and Coveney, P. V. (2010). Accurate ensemble molecular dynamics binding free energy ranking of multidrug-resistant HIV-1 proteases. J. Chem. Inf. Model. 50, 890-905.
99. Sanchez, R., Pieper, U., Melo, F., Eswar, N., Marti-Renom, M. A., Madhusudhan, M. S., Mirkovic, N., and Sali, A. (2000). Protein structure modeling for structural genomics. Nat. Struct. Biol. 7(Suppl.), 986-990.
100. Sandhu, K. S. (2009). Intrinsic disorder explains diverse nuclear roles of chromatin remodeling proteins. J. Mol Recognit. 22, 1-8.
101. Sandhu, K. S., and Dash, D. (2007). Dynamic alpha-helices: conformations that do not conform. Proteins 68,109-122.
102. Schames, J. R., Henchman, R. H., Siegel, J. S., Sotriffer, C. A., Ni, H., and McCammon, J. A. (2004). Discovery of a novel binding trench in HIV integrase. J. Med. Chem. 47, 1879-1881.
103. Shenderovich, M. D., Kagan, R. M., Heseltine, P. N., and Ramnarayan, K. (2003). Structure-based phenotyping predicts HIV-1 protease inhibitor resistance. Protein Sci. 12, 1706-1718.
104. Shojania, S., and ONeil, J. D. (2010). Intrinsic disorder and function of the HIV-1 Tat protein. Protein Pept. Lett. 17,999-1011.
105. Skasko, M., Wang, Y., Tian, Y., Tokarev, A., Munguia, J., Ruiz, A., Stephens, E. B., Opella, S. J., and Guatelli, J. (2012). HIV-1Vpu antagonizes the innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J. Biol Chem. 287, 58-67.
106. Soares, R. O., Batista, P. R., Costa, M. G., Dardenne, L. E., Pascutti, P. G., and Soares, M. A. (2010). Understanding the HIV-1 protease nelfinavir resistance mutation D30N in subtypes B and C through molecular dynamics simulations. J. Mol Graph. Model. 29, 137-147.
107. Song, H., Nakayama, E. E., Yokoyama, M., Sato, H., Levy, J. A., and Shioda, T. (2007). A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J. Virol. 81,7280-7285.
108. Steven, A. C., Heymann, J. B., Cheng, N., Trus, B. L., and Conway, J. E (2005). Virus maturation: dynamics and mechanism of a stabilizing structural transition that leads to infectivity. Curr. Opin. Struct. Biol. 15,227-236.
109. Stoica, I., Sadiq, S. K., and Coveney, P. V. (2008). Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases. J. Am. Chem. Soc. 130, 2639-2648.
110. Takada, S. (2012). Coarse-grained molecular simulations of largebiomolecules. Curr. Opin. Struct. Biol. 22, 130-137.
111. Thorpe, I. F., and Brooks, C. L. 3rd. (2007). Molecular evolution of affinity and flexibility in the immune system. Proc. Natl. Acad. Sci. U.S.A. 104,8821-8826.
112. Tobi, D., and Bahar, I. (2005). Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. Proc. Natl. Acad. Sci. U.S.A. 102, 18908-18913.
113. Unge, T., Montelius, I., Liljas, L., and Ofverstedt, L. G. (1986). The EDTA-treated expanded satellite tobacco necrosis virus: biochemical properties and crystallization. Virology 152,207-218.
114. van der Vries, E., Schutten, M., and Boucher, C. A. (2011). The potential for multidrug-resistant influenza. Curr. Opin. Infect. Dis. 24, 599-604.
115. Wang, J., Ma, C., Fiorin, G., Carnevale, V., Wang, T., Hu, F., Lamb, R. A., Pinto, L. H., Hong, M., Klein, M. L., and DeGrado, W E (2011). Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. J. Am. Chem. Soc. 133, 12834-12841.
116. White, K. L., Chen, J. M., Margot, N. A., Wrin, T., Petropoulos, C. J., Naeger, L. K., Swaminathan, S., and Miller, M. D. (2004). Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations. Antimicrob. Agents Chemother. 48, 992-1003.
117. Wittayanarakul, K., Aruksakunwong, O., Saenoon, S., Chantratita, W., Parasuk, V., Sompornpisut, P., and Hannongbua, S. (2005). Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations. Biophys. J. 88, 867-879.
118. Wright, D. W., and Coveney, P. V. (2011). Resolution of discordant HIV-1 protease resistance rankings using molecular dynamics simulations. J. Chem. Inf. Model. 51, 2636-2649.
119. Xu, Y., Colletier, J. P., Jiang, H., Silman, I., Sussman, J. L., and Weik, M. (2008). Inducedfit or preexisting equilibrium dynamics? lessons from protein crystallography and MD simulations on acetylcholinesteraseand implications for structure-based drug design. Protein Sci. 17, 601-605.
120. Xue, B., Mizianty, M. J., Kurgan, L., and Uversky, V. N. (2012). Protein intrinsic disorder as a flexible armor and a weapon of HIV-1. Cell. Mol. Life Sci. 69, 1211-1259.
121. Yokoyama, M., Naganawa, S., Yoshimura, K., Matsushita, S., and Sato, H. (2012). Structural dynamics of HIV-1 envelope gp120 outer domain with V3 loop. PLoS ONE 7:e37530. doi: 10.1371/journal.pone.0037530
122. Yoshimoto, K., Arora, K., and Brooks, C. L. 3rd. (2010). Hexameric helicase deconstructed: interplay of conformational changes and substrate coupling. Biophys. J. 98, 1449-1457.
123. Zhou, J., Zhang, Z., Mi, Z., Wang, X., Zhang, Q., Li, X., Liang, C., and Cen, S. (2012). Characterization of the interface of the bone marrow stromal cell antigen 2-Vpu protein complex via computational chemistry. Biochemistry 51, 1288-1296.
124. Zhou, Z., Madrid, M., Evanseck, J. D., and Madura, J. D. (2005). Effect of a bound non-nucleoside RT inhibitor on the dynamicsof wild-type and mutant HIV-1 reverse transcriptase. J. Am. Chem. Soc. 127, 17253-17260.